… who were eligible for β-blocker therapy for whom β-blocker therapy was newly started … for
the treatment groups included in this study (β-blocker therapy continued and β-blocker therapy …

… Trial in Congestive Heart Failure) (2) showed mortality benefits with beta-blocker treatment
in chronic heart failure, the question of how to handle beta- blockers in ADHF remains …

… function, and decrease mortality in adult patients with congestive heart failure caused by …
Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: A …

… Peak exercise oxygen consumption (VO 2 ) and the Heart Failure Survival Score (HFSS)
are used to risk stratify ambulatory patients with heart failure but were developed before the …

… use of beta blockers for the treatment of patients with HFpEF. … , the benefits and risks of
beta-blockers in this setting remain … use of beta blockers for the treatment of patients with HFpEF. …

… examined the efficacy of beta-blocker therapy in comparison with … in patients with HFpEF,
defined as left ventricular ejection … cardiovascular), rehospitalization (ie, all-cause and for heart …

… However, since beta-blocker therapy tends to restore the number of beta-receptors by … heart
failure, such treatment will have to achieve a sufficient high level in order to really block beta-…

… ventricular function in some children with dilated cardiomyopathy and congestive heart failure.
… may benefit most from beta-blocker therapy and which beta-blockers are most efficacious. …

… oral positive inotropic and beta-blocker therapy in patients with severe heart failure. …
beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. …

… We used the keywords atrial fibrillation, heart failure, beta-blocker therapy, beta-blockade,
and medical therapy and a combination of these terms and included papers published in …